CD8A and neoplasm: We found that tumor‐infiltrating Siglecg−/− CD8+ T cells expressed lower levels of inhibitory markers such as PD‐1 and Tim‐3 (Figure 5B) and exhibited increased IFN‐γ production compared to their WT counterparts (Figure 5C).